Purchase Order 75N93021P00221
Award Date 1/6/21
Potential Completion Date 2/5/21
Potential Value $25K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Auburn, CA, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Miltenyi Biotec, Inc. for $24,990.50 on January 25, 2021, for a GentleMACS Octo Dissociator under COVID-19 funding. Performance is at Auburn, California. The order was placed under firm fixed price terms with an ultimate completion date of February 26, 2021. The solicitation posted January 20, 2021, with a due date of January 24, 2021.</p>
- The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $59,710 purchase order to Miltenyi Biotec, Inc. to deliver two GentleMACS Octo Dissociator units with heaters. The place of performance will be in Auburn, California, and the period of performance is from September 10, 2023 through December 30, 2023. This firm fixed price contract supports NIH/NIAID research efforts through the procurement of specialized...
- <p>The National Cancer Institute awarded a purchase order to Miltenyi Biotec, Inc., valued at $25,881.00, on September 15, 2020, for one GentleMACS Octo Dissociator with heaters. The order carries a firm fixed price and is due for completion by October 15, 2020. Place of performance is Auburn, California. The procurement originated from a solicitation posted August 17, 2020, and due August 24, 2020, with no small business set-aside applied.</p>
- The U.S. National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), awarded a $4,881.00 firm-fixed-price purchase order contract to Miltenyi Biotec, Inc., a global biotechnology company, for a GENTLEMACS DISSOCIATOR. This contract is not set-aside and has an ultimate completion date of September 16, 2015. Miltenyi Biotec is a prime contractor with significant experience supplying specialized laboratory instruments, reagents, and services to...
- <p>The National Heart Lung and Blood Institute issued a purchase order to Miltenyi Biotec, Inc. for $20,680.00 on September 28, 2020, with an ultimate completion date of October 30, 2020. The order procures a GentleMACS Octo Dissociator with heaters for single cell preparations from tissues. Place of performance is Auburn, California. The purchase order is firm fixed price with no set-aside used.</p>
- <p>The NIH Clinical Center awarded a purchase order to Miltenyi Biotec, Inc. on June 23, 2020, for $24,980.62 to purchase a GentleMACS Octo Dissociator with heaters for dissociating lung tissue samples collected from patient donors into single-cell suspensions. The order carries no set-aside designation and is priced on a firm fixed price basis. Place of performance is Montgomery Village, Maryland. The ultimate completion date is August 26, 2020.</p>
- The Department of Health and Human Services National Institutes of Health National Institute of Neurological Disorders and Stroke awarded a $50,801.50 firm fixed price purchase order to Miltenyi Biotec, Inc. to procure two Miltenyi Biotec gentleMACS Octo Dissociator with Heaters or equivalent products. The products will support mission critical experiments being conducted by the Laboratory of Viral Immunology and Intravital Imaging at NINDS. Per the original solicitation, the contractor must...
- The Department of Health and Human Services, National Institutes of Health (NIH), National Cancer Institute (NCI) awarded a $29,858 firm-fixed-price purchase order to Miltenyi Biotec, Inc. to provide one Miltenyi Biotec GentleMACS Octo Dissociator with heating units. The equipment will be used to support the work of the NCI's Center for Immuno-Oncology, Laboratory of Tumor Immunology and Biology. There was no set-aside designation for this procurement, and the contract completion date is July...
- This federal contract award to Miltenyi Biotec, Inc., a global biotechnology company, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services. The award is for the purchase of 2 GENTLEMACS OCTO DISSOCIATORS WITH HEATING UNITS, totaling $48,320.00 on a firm fixed-price basis. The contract has an ultimate completion date of February 28, 2025. Miltenyi Biotec is a well-established federal...
- The Centers for Disease Control and Prevention awarded a purchase order to Miltenyi Biotec, Inc. for one GentleMACS Octo Dissociator with heating units and service plan on May 15, 2026, with a ceiling value of $38,037.25. No set-aside was used. Performance takes place in Atlanta, Georgia. The equipment enables simultaneous processing of eight biological samples in a closed, sterile system with integrated heating and validated protocols aligned with Quality Manual for Microbiological Laboratories...
The National Institute of Allergy and Infectious Diseases awarded a purchase order to Miltenyi Biotec, Inc. on January 6, 2021, for a GentleMACS Octo Dissociator, with a ceiling value of $24,984.62 under firm fixed price, no set-aside terms. Performance is located in Auburn, California. The order completed on February 5, 2021. The underlying solicitation was posted December 30, 2020, with a due date of January 5, 2021.
Generated 6/2/26, 9:51 AM
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
gentleMACS Octo Dissociator with Heaters | RFQ-NIAID-2057487 | Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases | Solicitation 1/1 | 12/30/20, 6:52 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $25.0k | 1/5/21 |